BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND B2M, P61769, 567, ENSG00000166710 AND Treatment
36 results:

  • 1. Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database.
    Dixit J; Gupta N; Kataki A; Roy P; Mehra N; Kumar L; Singh A; Malhotra P; Gupta D; Goyal A; Rajsekar K; Krishnamurthy MN; Gupta S; Prinja S
    Health Qual Life Outcomes; 2024 Mar; 22(1):26. PubMed ID: 38481231
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021.
    Abolhassani H; Avcin T; Bahceciler N; Balashov D; Bata Z; Bataneant M; Belevtsev M; Bernatowska E; Bidló J; Blazsó P; Boisson B; Bolkov M; Bondarenko A; Boyarchuk O; Bundschu A; Casanova JL; Chernishova L; Ciznar P; Csürke I; Erdős M; Farkas H; Fomina DS; Galal N; Goda V; Guner SN; Hauser P; Ilyina NI; Iremadze T; Iritsyan S; Ismaili-Jaha V; Jesenak M; Kelecic J; Keles S; Kindle G; Kondratenko IV; Kostyuchenko L; Kovzel E; Kriván G; Kuli-Lito G; Kumánovics G; Kurjane N; Latysheva EA; Latysheva TV; Lázár I; Markelj G; Markovic M; Maródi L; Mammadova V; Medvecz M; Miltner N; Mironska K; Modell F; Modell V; Mosdósi B; Mukhina AA; Murdjeva M; Műzes G; Nabieva U; Nasrullayeva G; Naumova E; Nagy K; Onozó B; Orozbekova B; Pac M; Pagava K; Pampura AN; Pasic S; Petrosyan M; Petrovic G; Pocek L; Prodeus AP; Reisli I; Ress K; Rezaei N; Rodina YA; Rumyantsev AG; Sciuca S; Sediva A; Serban M; Sharapova S; Shcherbina A; Sitkauskiene B; Snimshchikova I; Spahiu-Konjusha S; Szolnoky M; Szűcs G; Toplak N; Tóth B; Tsyvkina G; Tuzankina I; Vlasova E; Volokha A
    Front Immunol; 2022; 13():1032358. PubMed ID: 36605210
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors.
    Hong S; Zhao J; Wang S; Wang H; Lee JH; Farhadfar N; McGuirk JP; Savani BN; Shahrukh HK; Stiff P; Khera N; Hahn T; Loren AW; Jaglowski SM; Wood WA; Saber W; Cerny J; Holtan SG; Reynolds JM; Deol A; Jim H; Uberti J; Whalen V; Yi JC; Preussler J; Baker KS; Shaw BE; Devine S; Syrjala K; Majhail NS; Wingard JR; Al-Mansour Z
    Transplant Cell Ther; 2023 Mar; 29(3):202.e1-202.e8. PubMed ID: 36427784
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Performance of the Matsumiya scoring system in cervical cancer patients with bone metastasis: an external validation study.
    Wongyikul P; Wongchanudom S; Lumkul L; Isaradech N; Phanphaisarn A; Phinyo P; Pruksakorn D
    Int J Clin Oncol; 2023 Feb; 28(2):321-330. PubMed ID: 36402825
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Donor natural killer cells trigger production of β-2-microglobulin to enhance post-bone marrow transplant immunity.
    Ruggeri L; Urbani E; Chiasserini D; Susta F; Orvietani PL; Burchielli E; Ciardelli S; Sola R; Bruscoli S; Cardinale A; Pierini A; Piersma SR; Pasquino S; Locatelli F; Ramarli D; Velardi E; Binaglia L; Jimenez CR; Holländer GA; Velardi A
    Blood; 2022 Dec; 140(22):2323-2334. PubMed ID: 35984965
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast cancer Undergoing treatment with Aromatase Inhibitors.
    Mazziotti G; Pedersini R; Vena W; Cosentini D; Carrone F; Pigni S; Simoncini EL; Torrisi R; Zambelli A; Farina D; Balzarini L; Lania AG; Berruti A
    Calcif Tissue Int; 2022 Nov; 111(5):466-474. PubMed ID: 35902384
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG.
    van Houdt WJ; Fiore M; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss D; Gonzalez RJ; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Schrage Y; Cardona K; Pennacchioli E; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria SP; Canter R; Mullen JT; Callegaro D; Fairweather M; Miceli R; Raut CP; Gronchi A; Gladdy RA
    Cancer; 2020 Nov; 126(22):4917-4925. PubMed ID: 32797703
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Analysis of Progression Patterns and Failure Sites of Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations Receiving First-line treatment of Tyrosine Kinase Inhibitors.
    Li XY; Zhu XR; Zhang CC; Yu W; Zhang B; Shen TL; Zhang HY; Fu XL
    Clin Lung Cancer; 2020 Nov; 21(6):534-544. PubMed ID: 32505632
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survival in breast cancer patients with spine metastases: Prognostic assessment involving molecular markers.
    Amelot A; Terrier LM; Cristini J; Buffenoir K; Pascal-Moussellard H; Carpentier A; Bonaccorsi R; Le Nail LR; Mathon B
    Eur J Surg Oncol; 2020 Jun; 46(6):1021-1027. PubMed ID: 31899046
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Factors that Influence Chemotherapy treatment Rate in Patients With Upper Limb Osteosarcoma.
    Restrepo DJ; Huayllani MT; Boczar D; Sisti A; Spaulding AC; Moran SL; Aung T; Bagaria S; Manrique OJ; Forte AJ
    Anticancer Res; 2019 Oct; 39(10):5611-5615. PubMed ID: 31570457
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. M1b Disease in the 8th Edition of TNM Staging of Lung cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
    Park H; Dahlberg SE; Lydon CA; Araki T; Hatabu H; Rabin MS; Johnson BE; Nishino M
    Oncologist; 2019 Aug; 24(8):e749-e754. PubMed ID: 30696724
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Carr BR; Stewart EA; Archer DF; Al-Hendy A; Bradley L; Watts NB; Diamond MP; Gao J; Owens CD; Chwalisz K; Duan WR; Soliman AM; Dufek MB; Simon JA
    Obstet Gynecol; 2018 Nov; 132(5):1252-1264. PubMed ID: 30303923
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Relationship of peak serum methotrexate concentration to prognosis and drug tolerance in non-metastatic extremity osteosarcomas.
    Wang B; Yao H; Xie X; Yin J; Zou C; Huang G; Shen J
    Cancer Chemother Pharmacol; 2018 Aug; 82(2):221-227. PubMed ID: 29808416
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.
    Laird J; Ma J; Chau K; Chelius M; Shi W; Zhang Z; Lok BH; Yahalom J
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):670-678. PubMed ID: 29413280
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT.
    Baron F; Ruggeri A; Beohou E; Labopin M; Mohty M; Sanz J; Vigouroux S; Furst S; Bosi A; Chevallier P; Cornelissen JJ; Michallet M; Sierra J; Karakasis D; Savani BN; Gluckman E; Nagler A
    J Intern Med; 2018 Feb; 283(2):178-189. PubMed ID: 28977716
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Spinal bone metastases in colorectal cancer: a retrospective analysis of stability, prognostic factors and survival after palliative radiotherapy.
    Bostel T; Förster R; Schlampp I; Sprave T; Bruckner T; Nicolay NH; Welte SE; Debus J; Rief H
    Radiat Oncol; 2017 Jul; 12(1):115. PubMed ID: 28697786
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Outcomes and healthcare utilization in children and young adults with aplastic anemia: A multiinstitutional analysis.
    Gupta A; Fu P; Hashem H; Vatsayan A; Shein S; Dalal J
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28696061
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exploring the Clinicopathological Parameters Affecting the Outcome in Egyptian Patients with Multiple Myeloma.
    Sallam YA; Samra MA; Gaber AA
    Gulf J Oncolog; 2016 Jan; 1(20):51-63. PubMed ID: 27050180
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemia.
    Thompson PA; O'Brien SM; Xiao L; Wang X; Burger JA; Jain N; Ferrajoli A; Estrov Z; Keating MJ; Wierda WG
    Cancer; 2016 Feb; 122(4):565-73. PubMed ID: 26588193
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome.
    Buttigliero C; Vana F; Bertaglia V; Vignani F; Fiori C; Osella G; Porpiglia F; Tucci M; Scagliotti GV; Berruti A
    Endocrine; 2015 Sep; 50(1):223-30. PubMed ID: 25588772
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.